數(shù)字療法在心血管疾病中的臨床研究進(jìn)展

打開(kāi)文本圖片集

Clinical Research Proress of Digital Therapeutics in Cardiovascular Disease

MA Shuangliang1，ZHANG Junyan1，YANG Yamei2，HE Yong1，CHEN Zhongxiu'

（1. Departmentof Cardiology，West China Hospital，Sichuan UniversityChengdu 61o41，Sichuan，China；2.Dpartment

of Cardiology，Dali Prefecture People’s Hospital，Dali 671OOo，Yunnan，China）

【Abstract】Thispaperintroducestheconcept，characteristicsandroleofdigitaltherapeuticsinthepreventionandtreatmentof cardiovascularasatestcatiosinaageetfoosctorsndoaryeveidts challnges andoptimization measures，with theaimof providing referencesforconducting relevant studies in the future.

【Keywords】Cardiovasculardisease；Digital therapeutics；Risk factor；Secondary prevention；Diseasemanagement

隨著中國(guó)人口老齡化加速以及不健康生活方式的加劇，合并心血管疾病（cardiovasculardisease，CVD）危險(xiǎn)因素的人群巨大，CVD患病人數(shù)也呈持續(xù)增長(zhǎng)；在中國(guó)城鄉(xiāng)居民疾病死亡構(gòu)成比中，CVD占首位[1]根據(jù)《2016歐洲心血管疾病預(yù)防臨床實(shí)踐指南》[2]，吸煙、肥胖、高血壓、糖尿病、睡眠等CVD危險(xiǎn)因素大多是可預(yù)防或可治療的，有效的一級(jí)預(yù)防措施會(huì)顯著降低CVD的患病率。（剩余10026字）